Organisation paid for research Program year 2025 Source: CMS Open Payments

Start Mountain Region

Neither a doctor nor a teaching hospital

Research payments

$1,951,710

310 payments

Through program year 2025, Start Mountain Region is reported as receiving $1,951,710 in research payments, across 310 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$77,706	6
2024	Research	$300,053	41
2023	Research	$1,202,173	194
2022	Research	$371,778	69

Breakdown

Who paid Research payments · program years 2022–2025

Seattle Genetics, Inc. $1,415,120 249 payments
Pfizer Inc. $376,321 43 payments
Aadi Bioscience, Inc. $158,831 14 payments
AbbVie, Inc. $1,200 2 payments
Stemline Therapeutics Inc. $238 2 payments

Studies the money was for Research payments · program years 2022–2025

Open-Label Phase 1 Study of SGN-B7H4V for Solid Tumors $834,766 143 payments
A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors $451,270 82 payments
An Openlabel Phase 1 Study to Investigate Sgnceacam5c in Adults With Advanced Solid Tumors $167,042 9 payments
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment $158,831 14 payments
A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors $129,083 24 payments
A Phase 1 Study of Sgnpdl1v in Advanced Solid Tumors $90,745 15 payments
An Openlabel Phase 1 Study to Investigate Sgnceacam5c in Adults With Advanced Solid Tumors $76,506 4 payments
Openlabel Phase 1 Study of Sgnb7h4v for Solid Tumors $28,108 11 payments
A Phase 1 Study of Sgnalpv in Advanced Solid Tumors $13,920 4 payments
A Global First-in-Human Study in NSCLC, HNSCC and Solid Tumors with Azirkitug (ABBV-514) as a Single Agent and in Combination with Budigalimab or Bevacizumab $750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.